Lipid Association of India (LAI) expert consensus statement on management of dyslipidaemia in Indians 2017: part 2
2017
These Lipid Association of India (LAI) recommendations refer to specific patient populations. They follow the previously published LAI part 1 recommendations. These part 2 LAI recommendations focus on specific patient groups. These include patients with heart failure, chronic kidney disease, non-alcoholic fatty liver disease, cerebrovascular disease, thyroid disorders, inflammatory joint diseases, familial hypercholesterolaemia and human immunodeficiency virus infection. We also consider women, the elderly and post-transplantation patients. The current recommendations are based, as much as possible, on available data from Indian populations.
Keywords:
- Endocrinology
- Immunodeficiency
- Kidney disease
- Diabetes mellitus
- Fatty liver
- Medicine
- Disease
- Stroke
- Heart failure
- Alt alanine aminotransferase
- Internal medicine
- Family medicine
- expert consensus
- MI - Myocardial infarction
- CK - Creatine kinase
- DHA - Docosahexaenoic acid
- CKD - chronic kidney disease
- NSAID - Non-steroidal anti-inflammatory drug
- DM - Diabetes mellitus
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
665
References
17
Citations
NaN
KQI